CENTRAL NERVOUS SYSTEM LYMPHOMA

Clinical trials for CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear

Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 4 Completed 2

New drug combo targets rare and aggressive brain cancer

Disease control Not yet recruiting

This study is testing whether adding the drug zanubrutinib to standard chemotherapy helps control a rare and aggressive type of brain cancer called primary central nervous system lymphoma. It will enroll 19 newly diagnosed patients in China to see if this combination leads to com…

Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA

Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

CENTRAL NERVOUS SYSTEM LYMPHOMA

Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear

New drug combo targets rare and aggressive brain cancer